Insider Transactions in Q3 2024 at Relay Therapeutics, Inc. (RLAY)
Insider Transaction List (Q3 2024)
Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
---|---|---|---|---|---|
Sep 27
2024
|
Brian Adams Chief Legal Officer |
SELL
Open market or private sale
|
Direct |
295
-0.09%
|
$2,065
$7.51 P/Share
|
Sep 27
2024
|
Donald A Bergstrom President, R&D |
SELL
Open market or private sale
|
Direct |
648
-0.12%
|
$4,536
$7.51 P/Share
|
Sep 27
2024
|
Thomas Catinazzo Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
6,457
-1.01%
|
$45,199
$7.49 P/Share
|
Sep 27
2024
|
Peter Rahmer |
SELL
Open market or private sale
|
Direct |
245
-0.06%
|
$1,715
$7.51 P/Share
|
Jul 31
2024
|
Peter Rahmer |
SELL
Open market or private sale
|
Direct |
13,708
-3.38%
|
$109,664
$8.19 P/Share
|
Jul 30
2024
|
Peter Rahmer |
SELL
Open market or private sale
|
Direct |
15,128
-3.6%
|
$121,024
$8.28 P/Share
|
Jul 29
2024
|
Brian Adams Chief Legal Officer |
SELL
Open market or private sale
|
Direct |
1,638
-0.5%
|
$13,104
$8.85 P/Share
|
Jul 29
2024
|
Donald A Bergstrom President, R&D |
SELL
Open market or private sale
|
Direct |
2,698
-0.51%
|
$21,584
$8.85 P/Share
|
Jul 29
2024
|
Peter Rahmer |
SELL
Open market or private sale
|
Direct |
13,523
-1.56%
|
$108,184
$8.68 P/Share
|
Jul 29
2024
|
Thomas Catinazzo Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
10,780
-1.64%
|
$86,240
$8.68 P/Share
|
Jul 26
2024
|
Sanjiv Patel President and CEO |
SELL
Open market or private sale
|
Direct |
36,706
-4.57%
|
$330,354
$9.07 P/Share
|
Jul 26
2024
|
Sanjiv Patel President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
36,706
+4.37%
|
$183,530
$5.04 P/Share
|
Jul 25
2024
|
Sanjiv Patel President and CEO |
SELL
Open market or private sale
|
Direct |
50,000
-6.13%
|
$450,000
$9.16 P/Share
|
Jul 25
2024
|
Sanjiv Patel President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
50,000
+5.77%
|
$250,000
$5.04 P/Share
|